Teva Pharma (TEVA) Settles with Ven-A-Care; To Record Charge of $315M for Q409
Tweet Send to a Friend
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that several of its subsidiaries in the United States reached a settlement ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE